• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/16/21 12:23:53 PM ET
    $CFX
    Fluid Controls
    Capital Goods
    Get the next $CFX alert in real time by email
    SC 13G/A 1 cfx13gadec20.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5) Colfax CORP (Name of Issuer) COMMON STOCK (Title of Class of Securities) 194014106 (CUSIP NUMBER) December 31, 2020 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 6,417,757 6. Shared Voting Power* 0 7. Sole Dispositive Power* 16,546,189 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 16,546,189 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 13.9% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. 1. Name of Reporting Person T. ROWE PRICE MID-CAP GROWTH FUND, INC. 52-1784828 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 8,250,000 6. Shared Voting Power* 0 7. Sole Dispositive Power* 0 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 8,250,000 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 6.9% 12. Type of Reporting Person IV *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: Colfax CORP Item 1(b) Address of Issuer's Principal Executive Offices: 420 NATIONAL BUSINESS PARKWAY ,5TH FLOOR ,ANNAPOLIS JUNCTION, MARYLAND 20701 Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. ("Price Associates") (2) T. ROWE PRICE MID-CAP GROWTH FUND, INC. X Attached as Exhibit A is a copy of an agreement between the Persons Filing (as specified hereinabove) that this Schedule 13G is being filed on behalf of each of them. Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland (2) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 194014106 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 X Investment Company registered under Section 8 of the Investment Company Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class Not Applicable Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. (2) With respect to securities owned by any one of the T. Rowe Price Funds, only the custodian for each of such Funds, has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. No other person is known to have such right, except that the shareholders of each such Fund participate proportionately in any dividends and distributions so paid. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: February 16, 2021 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President T. ROWE PRICE MID-CAP GROWTH FUND, INC. Date: February 16, 2021 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President 12/31/2020 EXHIBIT A AGREEMENT JOINT FILING OF SCHEDULE 13G Price Associates, Inc. (an investment adviser registered under the Investment Advisers Act of 1940), and T. ROWE PRICE MID-CAP GROWTH FUND, INC., all of which are Maryland corporations, hereby agree to file jointly the statement on Schedule 13G to which this Agreement is attached, and any amendments thereto which may be deemed necessary, pursuant to Regulation 13D-G under the Securities Exchange Act of 1934. It is understood and agreed that each of the parties hereto is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such party contained therein, but such party is not responsible for the completeness or accuracy of information concerning the other party unless such party knows or has reason to believe that such information is inaccurate. It is understood and agreed that a copy of this Agreement shall be attached as an exhibit to the statement on Schedule 13G, and any amendments hereto, filed on behalf of each of the parties hereto. T. ROWE PRICE ASSOCIATES, INC. Date: February 16, 2021 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President T. ROWE PRICE MID-CAP GROWTH FUND, INC. Date: February 16, 2021 Signature: /s/ David Oestreicher Name & Title: David Oestreicher, Executive Vice President
    Get the next $CFX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CFX

    DatePrice TargetRatingAnalyst
    3/2/2022$8.00 → $7.00Sector Perform
    RBC Capital
    2/23/2022$58.00 → $52.00Buy
    Stifel
    2/8/2022Buy → Neutral
    Seaport Global
    1/28/2022$51.00 → $45.00Equal-Weight
    Morgan Stanley
    1/14/2022$56.00 → $51.00Equal-Weight
    Morgan Stanley
    1/6/2022$45.00Hold
    Loop Capital
    11/5/2021$57.00 → $60.00Overweight
    Keybanc
    10/20/2021$12.00 → $9.00Outperform → Sector Perform
    RBC Capital
    More analyst ratings

    $CFX
    SEC Filings

    See more
    • Colfax Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Enovis CORP (0001420800) (Filer)

      6/30/22 8:23:02 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form 11-K filed by Colfax Corporation

      11-K - Enovis CORP (0001420800) (Filer)

      6/29/22 3:02:16 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Colfax Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Enovis CORP (0001420800) (Filer)

      6/13/22 4:14:55 PM ET
      $CFX
      Fluid Controls
      Capital Goods

    $CFX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Enovis (formerly Colfax) Completes Spin-off of ESAB Corporation

      Wilmington, DE, April 05, 2022 (GLOBE NEWSWIRE) -- Enovis Corporation ("Enovis" or the "Company") (NYSE:ENOV), an innovation-driven medical technology growth company formerly known as Colfax Corporation, announced today the completion of its previously announced separation (the "Separation") of its fabrication technology business into an independent, publicly traded company, ESAB Corporation ("ESAB") (NYSE:ESAB). Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio. Enovis and ESAB common stock will each begin regular-way trading today, April 5, 2022, on t

      4/5/22 6:00:00 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • ESAB Set to Join S&P MidCap 400; PROG Holdings to Join S&P SmallCap 600

      NEW YORK, March 30, 2022 /PRNewswire/ -- ESAB Corp. (NYSE:ESAB) will be added to the S&P MidCap 400 effective prior to the opening of trading on Tuesday, April 5. Effective prior to the opening of trading on Wednesday, April 6, S&P MidCap 400 constituent PROG Holdings Inc. (NYSE:PRG) will replace Fiesta Restaurant Group Inc. (NASD: FRGI) in the S&P SmallCap 600. S&P MidCap 400 constituent Colfax Corp. (NYSE:CFX) is spinning off ESAB in a transaction expected to be completed on April 5. Post spin-off, Colfax will be renamed Enovis Corp. (NYSE:ENOV) and will remain in the S&P MidCap 400. PROG Holdings is more representative of the small-cap market space and Fiesta Restaurant Group is no longer

      3/30/22 8:21:00 PM ET
      $CFX
      $FRGI
      $PRG
      $SPGI
      Fluid Controls
      Capital Goods
      Restaurants
      Consumer Discretionary
    • Colfax Announces Board of Directors for Post-Spinoff ESAB

      Wilmington, DE, March 28, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company which will renamed Enovis Corporation ("Enovis") following the expected April 4, 2022 consummation of the Company's previously announced spin-off of its fabrication technology business (the "Separation"), which will operate as ESAB Corporation ("ESAB") after the Separation, today announced the future composition of the full ESAB Board of Directors (the "Board"). Following the Separation, Mitchell P. Rales will serve as chairman of the Board, and current Colfax directors Patrick W. Allender, Rhonda L. Jordan, Didier Teirlinck and Rajiv Vinnakota will serve as directo

      3/28/22 6:30:00 AM ET
      $CFX
      Fluid Controls
      Capital Goods

    $CFX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $CFX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SEC Form 4: Kleckner John sold $2,496 worth of shares (44 units at $56.73), decreasing direct ownership by 3% to 1,661 units (for tax liability)

      4 - Enovis CORP (0001420800) (Issuer)

      7/21/22 8:00:15 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form 4: Perfall A Clayton was granted 432 shares, increasing direct ownership by 1% to 31,073 units

      4 - Enovis CORP (0001420800) (Issuer)

      7/1/22 7:00:22 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form 4: Lalor Angela S was granted 319 shares, increasing direct ownership by 16% to 2,363 units

      4 - Enovis CORP (0001420800) (Issuer)

      7/1/22 7:00:17 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • RBC Capital reiterated coverage on Canfor Pulp Products with a new price target

      RBC Capital reiterated coverage of Canfor Pulp Products with a rating of Sector Perform and set a new price target of $7.00 from $8.00 previously

      3/2/22 7:16:55 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Stifel reiterated coverage on Colfax with a new price target

      Stifel reiterated coverage of Colfax with a rating of Buy and set a new price target of $52.00 from $58.00 previously

      2/23/22 8:55:36 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Colfax downgraded by Seaport Global

      Seaport Global downgraded Colfax from Buy to Neutral

      2/8/22 6:36:17 AM ET
      $CFX
      Fluid Controls
      Capital Goods

    $CFX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Colfax Corporation

      SC 13G - Enovis CORP (0001420800) (Subject)

      4/21/22 3:32:21 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form SC 13G/A filed by Colfax Corporation (Amendment)

      SC 13G/A - Colfax CORP (0001420800) (Subject)

      3/11/22 2:13:51 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • SEC Form SC 13G/A filed by Colfax Corporation (Amendment)

      SC 13G/A - Colfax CORP (0001420800) (Subject)

      2/9/22 3:43:31 PM ET
      $CFX
      Fluid Controls
      Capital Goods

    $CFX
    Financials

    Live finance-specific insights

    See more
    • Colfax Corporation Announces Fourth Quarter and Full Year 2021 Results

      Strong operating performance supported $0.06 EPS from continuing operations and $0.59 of adjusted EPSAchieved a strong quarter of cash flow, contributing to full year operating cash flow of $356 million and free cash flow of $277 millionPositioned for separation into two independent public companies near the end of the first quarter 2022 with strong growth outlooks for both businesses Wilmington, DE, Feb. 22, 2022 (GLOBE NEWSWIRE) --  Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced its financial results for the fourth quarter and fiscal year 2021 and provided additional updates. The Company reported fourth quarter net income from c

      2/22/22 6:00:00 AM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Colfax Schedules Fourth Quarter and Fiscal Year 2021 Earnings Release and Conference Call

            Wilmington DE, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced that it will issue a press release providing financial results for the fourth quarter and fiscal year 2021 on the morning of Tuesday, February 22, 2022. The Company will hold a conference call to discuss these results beginning at 8:00 a.m. Eastern on that day, which will be open to the public by calling +1-877-303-7908 (U.S. callers) and +1-678-373-0875 (International callers) and referencing the conference ID number 7466839 and through webcast via Colfax's website www.colfaxcorp.com under the "Investors" section. Colfax's financial results

      1/20/22 5:00:23 PM ET
      $CFX
      Fluid Controls
      Capital Goods
    • Colfax Corporation Announces Third Quarter 2021 Results

                                                     Posted $0.17 EPS from continuing operations and $0.54 of adjusted EPSIncreased sales 20% to $966 million including a 15% organic sales-per-day improvementReported strong progress on integration of acquisitionsAnnounced continued progress to Q1 2022 separation including new post-separation name for MedTech growth company WILMINGTON, DE, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Colfax Corporation (NYSE:CFX), a leading diversified technology company, today announced its financial results for the third quarter of 2021 and provided other updates. The Company reported third quarter net income from continuing operations of $27 million, or $0

      11/4/21 6:00:00 AM ET
      $CFX
      Fluid Controls
      Capital Goods